- TL 1998 5-8
Treatment Action Group (TAG): Volume 5, Issue 8 -October 1998 On Friday September 18, the FDA granted accelerated approval to DuPont Pharmaceuticals' efavirenz, also known as Sustiva, a potent non-nucleoside reverse transcriptase inhibitor which was all the rage at this year's two big international AIDS conferences. FD
- TL 1998 5-7
TAGline: Double Summer (Geneva) Issue Treatment Action Group (TAG): Volume 5, Issue 7 -August/September 1998 "Me-too"s Rule Geneva 'New Agents' Sessions Betray Dearth of Interest in Imaginative (or Costly) Drug Development Everything new is old again What is becoming clearer and clearer as these national and internatio
- TL 1998 5-6
Treatment Action Group (TAG): Volume 5, Issue 6 -July 1998 Empyrrhic Victory Jubilation, and Skepticism, Greet Announcement of First Phase III Trial of an AIDS Vaccine Watershed --or Waterworld? This June, the FDA gave the go-ahead to VaxGen, Inc., a subsidiary of Genentech, the biotechnology firm, to conduct the first
- TL 1998 5-5
Treatment Action Group (TAG): Volume 5, Issue 4 -May 1998 Reservoirs Dog Joint TAG-AmFAR Scientific Think Tank Assembles Eradication Experts for Marathon Brainstorming Session Tissue samples could be key The Treatment Action Group and the American Foundation for AIDS Research held a groundbreaking scientific workshop 2
- TL 1998 5-4
Treatment Action Group (TAG): Volume 5, Issue 4 -May 1998 Reservoirs Dog Joint TAG-AmFAR Scientific Think Tank Assembles Eradication Experts for Marathon Brainstorming Session Tissue samples could be key The Treatment Action Group and the American Foundation for AIDS Research held a groundbreaking scientific workshop 2
- TL 1998 5-3
Treatment Action Group (TAG): Volume 5, Issue 3 -April 1998 Designs Unforgiving U.S. and French Investigators Alike Are 'Shocked, shocked' to Learn of Maintenance Protocol's Failure Might the Brits get it right? First it was kidney stones. Blood in the urine. Hyperbilirubinemia. Yellowed whites of the eyes. An unquanti
- TL 1998 5-2
Treatment Action Group (TAG): Volume 5, Issue 2 -March 1998 Swift Success CDC/Thai Vertical Transmission Results Silence Critics and Pave Way for Prevention of Millions of Infections Worldwide But who will bear the cost? Four years ago, results of ACTG 076 showed that HIV-infected pregnant women treated with a complex
- TL 1998 5-1
Treatment Action Group (TAG): Volume 5, Issue 1 -January 1998 Vaccine Tug-of-War Laboratory Purists and Renegade Empiricists Duke It Out Over How to Proceed with Vaccine Development Efforts Current Products Certain to Fail. Although significant scientific hurdles continue to impede progress toward the development of an